Viking Therapeutics (VKTX) Other Working Capital Changes (2014 - 2026)

Viking Therapeutics has reported Other Working Capital Changes for 8 years, with the latest figure at -$191000.0 in Q2 2026.

• Quarterly Other Working Capital Changes fell 46.92% year-over-year to -$191000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$576000.0 (down 19.25% YoY) and the FY2025 annual result came in at -$505000.0, down 25.62% from the prior year.
• Other Working Capital Changes fell to -$191000.0 in Q2 2026 per VKTX's latest filing, from -$139000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $10.7 million in Q2 2026 and troughed at -$14.3 million in Q4 2025.
• A 5-year average of $421277.8 and a median of $68500.0 in 2023 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes jumped 196.51% in 2022, then plunged 206.02% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$84000.0 in 2022, then dropped by 3.57% to -$87000.0 in 2023, then slumped by 47.13% to -$128000.0 in 2024, then increased by 9.38% to -$116000.0 in 2025, then tumbled by 64.66% to -$191000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$191000.0, -$139000.0, and -$116000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.